Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

Sep 21, 2023

SELL
$59.95 - $92.06 $185,845 - $285,386
-3,100 Reduced 2.02%
150,000 $10.8 Million
Q1 2022

May 16, 2022

SELL
$59.95 - $92.06 $185,845 - $285,386
-3,100 Reduced 2.02%
150,000 $10.9 Million
Q4 2021

Sep 21, 2023

BUY
$81.07 - $121.29 $10.3 Million - $15.4 Million
127,100 Added 488.85%
153,100 $12.4 Million
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $10.3 Million - $15.4 Million
127,100 Added 488.85%
153,100 $12.4 Million
Q3 2021

Sep 21, 2023

SELL
$101.99 - $166.36 $1.42 Million - $2.31 Million
-13,900 Reduced 34.84%
26,000 $3.03 Million
Q3 2021

Nov 15, 2021

SELL
$101.99 - $166.36 $1.42 Million - $2.31 Million
-13,900 Reduced 34.84%
26,000 $3.03 Million
Q2 2021

Sep 21, 2023

BUY
$141.6 - $179.06 $2.59 Million - $3.28 Million
18,300 Added 84.72%
39,900 $6.62 Million
Q2 2021

Aug 20, 2021

SELL
$141.6 - $179.06 $559 Million - $707 Million
-3,950,100 Reduced 99.0%
39,900 $6.62 Million
Q2 2021

Aug 16, 2021

BUY
$141.6 - $179.06 $562 Million - $711 Million
3,968,400 Added 18372.22%
3,990,000 $6.62 Million
Q1 2021

Sep 21, 2023

SELL
$132.81 - $182.18 $17.1 Million - $23.4 Million
-128,400 Reduced 85.6%
21,600 $3.01 Million
Q1 2021

May 14, 2021

BUY
$132.81 - $182.18 $2.87 Million - $3.94 Million
21,600 New
21,600 $3.01 Million
Q4 2020

Feb 16, 2021

SELL
$138.17 - $184.34 $5.53 Million - $7.37 Million
-40,000 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$114.09 - $145.51 $2.28 Million - $2.91 Million
-20,000 Reduced 33.33%
40,000 $5.57 Million
Q1 2020

May 15, 2020

BUY
$70.23 - $144.31 $4.21 Million - $8.66 Million
60,000 New
60,000 $6 Million
Q4 2019

Feb 13, 2020

SELL
$76.41 - $117.54 $2.41 Million - $3.71 Million
-31,600 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$61.52 - $91.1 $1.88 Million - $2.78 Million
30,500 Added 2772.73%
31,600 $2.72 Million
Q2 2019

Aug 14, 2019

BUY
$58.04 - $66.99 $63,844 - $73,689
1,100 New
1,100 $71,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $162M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.